Lexology January 15, 2026
The Make America Health Again (MAHA) Commission, introduced in 2025, is shaping conversations about healthcare policy and industry practices. While its primary mission is to address chronic disease in children, its recommendations touch on pharmaceutical marketing, prescriber education, and consumer engagement.
The United States and New Zealand are the only high-income countries that allow for direct-to-consumer (DTC) advertising of prescription drugs. In the U.S., DTC advertising spending has seen a dramatic increase over the last several decades.
In its recent “Make Our Children Healthy Again” report, the MAHA Commission puts DTC pharmaceutical advertising under the microscope, writing:
“FDA, HHS, the Federal Trade Commission (FTC), and Department of Justice will increase oversight and enforcement under current authorities for violations of...
Today's Sponsors
Today's Sponsor